Adaptin Bio, Inc.

10-K/A Fiscal year ended 2025-12-31 Jun 12, 2026 10-Q Quarter ended 2026-03-31 May 15, 2026 8-K Other events Apr 6, 2026 10-K Fiscal year ended 2025-12-31 Apr 1, 2026 8-K Entered a material agreement; Unregistered sale of equity Dec 23, 2025 10-Q Quarter ended 2025-09-30 Nov 14, 2025 8-K Director or officer change; Other events Oct 6, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-Q Quarter ended 2025-03-31 May 15, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K/A Completed an acquisition or disposition Apr 15, 2025 8-K Other events Apr 9, 2025 8-K Entered a material agreement; Completed an acquisition or disposition; Unregistered sale of equity; Modified rights of security holders; Changed accountants; Change in control; Director or officer change; Amended charter or bylaws; Item 5.05; Item 5.06 Feb 18, 2025 10-Q Quarter ended 2024-09-30 Nov 14, 2024 10-Q Quarter ended 2024-06-30 Aug 14, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 10-K Fiscal year ended 2023-12-31 Apr 1, 2024 10-Q Quarter ended 2023-09-30 Nov 14, 2023 EFFECT Jul 22, 2026 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-1 Jul 21, 2026 D/A Item 06b Jun 22, 2026 424B3 PROSPECTUS SUPPLEMENT Jun 12, 2026 424B3 PROSPECTUS SUPPLEMENT May 18, 2026 NT 10-K NOTIFICATION OF LATE FILING Apr 1, 2026 D/A Item 06b Mar 23, 2026 D/A Item 06b Feb 20, 2026 D Item 06b Jan 5, 2026 424B3 PROSPECTUS SUPPLEMENT Nov 17, 2025 424B3 PROSPECTUS SUPPLEMENT Oct 7, 2025 4 PRIMARY DOCUMENT Sep 10, 2025 4 PRIMARY DOCUMENT Sep 10, 2025 4 PRIMARY DOCUMENT Sep 10, 2025 4 PRIMARY DOCUMENT Sep 10, 2025 4 PRIMARY DOCUMENT Sep 10, 2025 4 PRIMARY DOCUMENT Sep 10, 2025 4 PRIMARY DOCUMENT Sep 10, 2025 S-8 REGISTRATION STATEMENT Aug 15, 2025 424B3 Aug 15, 2025 424B3 PROSPECTUS Aug 5, 2025 EFFECT Aug 4, 2025